Silence Therapeutics Plc Ord 5P is listed on the London Stock Exchange trading with ticker code SLN.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £5,757m, with approximately 71m shares in issue. Over the last year, Silence Therapeutics Plc share price has been traded in a range of 135, hitting a high of 175.00, and a low of 40.00.
Silence Therapeutics Plc, officially known as Silence Therapeutics Plc Ord 5P was formed in November of 1994, making the company twenty five years old. The company filed its latest accounts on 31st December 2014, showing a turnover of approximately 15 thousand GBX, and a pre-tax profit margin of -79866.67%. Silence Therapeutics Plc currently has 6 directors, and has had 33 previous directors over the last 25 years. In the last set of accounts produced by Pricewaterhousecoopers Llp, the company showed 6.28 million paid in salaries to the staff, with the directors receiving an average 131 thousand each. In the accounts filed in 2014, the company paid 0 in dividends. These accounts also showed Silence Therapeutics Plc to have a net worth of 20.68 million, with 16.86 million held in cash.
Silence Therapeutics Plc is in the Medicine and Biotech Research sector.
|Inland Homes Plc (INL.L)|
|Summit Therapeutics Plc (SUMM.L)|
|Quadrise Fuels International Plc (QFI.L)|
|Cppgroup Plc (CPP.L)|
|Central Asia Metals Plc (CAML.L)|
|Shares in Issue||71m|
|52 Week High||175.00|
|52 Week Low||40.00|